Low molecular weight heparin (nadroparin) improves placental permeability in rats with gestational diabetes mellitus via reduction of tight junction factors.
Animals
Diabetes, Gestational
/ blood
Disease Models, Animal
Female
Glycation End Products, Advanced
/ blood
NF-kappa B
/ metabolism
Nadroparin
/ pharmacology
Permeability
Placenta
/ drug effects
Pregnancy
RNA, Messenger
/ genetics
Rats, Sprague-Dawley
Receptor for Advanced Glycation End Products
/ genetics
Tight Junction Proteins
/ metabolism
Tight Junctions
/ drug effects
Vascular Endothelial Growth Factor A
/ genetics
GdM
placental permeability
TJ
raGe
low molecular weight heparin
nF-κB
Journal
Molecular medicine reports
ISSN: 1791-3004
Titre abrégé: Mol Med Rep
Pays: Greece
ID NLM: 101475259
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
06
03
2019
accepted:
15
10
2019
entrez:
25
1
2020
pubmed:
25
1
2020
medline:
7
10
2020
Statut:
ppublish
Résumé
Placental structural abnormalities and dysfunction in those with gestational diabetes mellitus (GDM) can lead to increased placental permeability, which is in turn related to a poorer maternal and fetal prognosis. The present study sought to assess whether increased placental permeability in rats with GDM was accompanied by alterations in tight junction (TJ) factors and to evaluate the impact of low molecular weight heparin (LMWH) on these factors. The present study was conducted using pregnant female rats that were randomized into control, GDM and GDM + LMWH groups. Diabetes was induced via intraperitoneal administration of streptozotocin to rats in the GDM and GDM + LMWH groups, whereas rats in the GDM + LMWH group received daily subcutaneous LMWH starting on day 5 of pregnancy. On gestational day 16, all rats were sacrificed and Evans Blue (EB) assay was used to gauge vascular permeability based on EB dye leakage. Transmission electron microscopy was further used to assess TJ structures, and the TJ proteins zonular occludens‑1 (ZO‑1) and occludin (OCLN) were assessed using immunohistochemistry and western blotting. Blood samples were obtained from the abdominal aorta for ELISA measurements of advanced glycation end products (AGEs) concentrations, and placental receptor for AGEs (RAGE) and vascular endothelial growth factor (VEGF) expression was assessed using reverse transcription‑quantitative PCR. In addition, western blotting was used to measure placental NF‑κB. Compared with in the control group, EB leakage was markedly increased in GDM group rats; this was associated with reduced ZO‑1 and OCLN expression. Conversely, LMWH attenuated this increase in placental permeability in rats with GDM and also mediated a partial recovery of ZO‑1 and OCLN expression. Blood glucose and serum AGEs concentrations did not differ between the GDM and GDM + LMWH groups. Furthermore, LMWH treatment resulted in decreases in RAGE and VEGF mRNA expression levels, which were upregulated in the GDM group, whereas it had the opposite effect on the expression of NF‑κB. In conclusion, GDM was associated with increased placental permeability and this may be linked with changes in TJs. LMWH intervention mediated protection against this GDM‑associated shift in placental permeability via the RAGE/NF‑κB pathway.
Identifiants
pubmed: 31974593
doi: 10.3892/mmr.2019.10868
pmc: PMC6947895
doi:
Substances chimiques
Glycation End Products, Advanced
0
NF-kappa B
0
Nadroparin
0
RNA, Messenger
0
Receptor for Advanced Glycation End Products
0
Tight Junction Proteins
0
Vascular Endothelial Growth Factor A
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
623-630Références
Diabetologia. 2000 Sep;43(9):1185-96
pubmed: 11043866
Res Pract Thromb Haemost. 2017 Jun 20;1(1):23-32
pubmed: 30046671
Carbohydr Polym. 2017 Mar 15;160:71-81
pubmed: 28115102
Obstet Gynecol Int. 2015;2015:283124
pubmed: 26379710
Pharmacol Res. 2005 Jan;51(1):59-67
pubmed: 15519536
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):913-9
pubmed: 23786818
APMIS. 2006 Dec;114(12):874-83
pubmed: 17207088
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar;160(1):70-5
pubmed: 26607295
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Diabetologia. 2001 Feb;44(2):129-46
pubmed: 11270668
J Matern Fetal Neonatal Med. 2019 Sep;32(17):2783-2789
pubmed: 29560756
Ann N Y Acad Sci. 2008 Mar;1123:134-45
pubmed: 18375586
J Mol Med (Berl). 2017 May;95(5):535-552
pubmed: 28132078
Int J Neurosci. 2014 Feb;124(2):75-81
pubmed: 23855502
J Clin Invest. 2006 Nov;116(11):2955-63
pubmed: 17053836
Folia Histochem Cytobiol. 2009;47(1):17-23
pubmed: 19419932
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):2949-2956
pubmed: 29890222
Front Physiol. 2016 Mar 31;7:119
pubmed: 27065887
Placenta. 2000 Jul-Aug;21(5-6):547-57
pubmed: 10940205
J Anat. 2009 Jul;215(1):69-76
pubmed: 19563553
Gynecol Endocrinol. 2019 Sep;35(9):811-814
pubmed: 30964350
World J Diabetes. 2015 Mar 15;6(2):338-44
pubmed: 25789116
Diabetologia. 2004 Apr;47(4):695-709
pubmed: 15298347
Pediatr Dev Pathol. 2015 Jan-Feb;18(1):17-23
pubmed: 25361430
Rom J Morphol Embryol. 2018;59(2):455-467
pubmed: 30173249
J Cell Physiol. 2019 Jan 26;:null
pubmed: 30684278
Lancet. 2016 Nov 26;388(10060):2629-2641
pubmed: 27720497
J Diabetes Complications. 1999 Jul-Aug;13(4):187-90
pubmed: 10616857
Pathol Oncol Res. 2009 Dec;15(4):689-92
pubmed: 19757196
Placenta. 2018 Apr;64 Suppl 1:S9-S15
pubmed: 29370939
Neuro Endocrinol Lett. 2015;36(2):101-5
pubmed: 26071574
Cell Signal. 2013 Nov;25(11):2185-97
pubmed: 23838007
Hypertens Pregnancy. 2008;27(4):374-86
pubmed: 19003638
J Perinatol. 2009 Jul;29(7):483-8
pubmed: 19279648
Intensive Care Med Exp. 2016 Dec;4(1):33
pubmed: 27704481
Biol Reprod. 2018 Nov 1;99(5):1082-1090
pubmed: 29860275
Kidney Int. 2007 Jan;71(2):126-33
pubmed: 17149374
Semin Ophthalmol. 1999 Dec;14(4):240-8
pubmed: 10758225
Inflammation. 2012 Jun;35(3):1213-21
pubmed: 22350949
Clin Chim Acta. 2019 Feb;489:203-211
pubmed: 29223764
J Vis Exp. 2013 Mar 16;(73):e50062
pubmed: 23524912
N Engl J Med. 2008 Oct 9;359(15):1577-89
pubmed: 18784090
Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111
pubmed: 11108954
Mol Cell Biol Res Commun. 2000 Jun;3(6):380-8
pubmed: 11032761
Cancer Sci. 2013 Jun;104(6):740-9
pubmed: 23421467